NYSE American - Delayed Quote • USD
Senseonics Holdings, Inc. (SENS)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 7:58 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.03 | -0.03 | -0.13 | -0.12 |
Low Estimate | -0.03 | -0.04 | -0.14 | -0.13 |
High Estimate | -0.03 | -0.03 | -0.12 | -0.11 |
Year Ago EPS | 0 | -0.04 | -0.11 | -0.13 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 4.6M | 5.28M | 26M | 40.39M |
Low Estimate | 4M | 4.9M | 24M | 37M |
High Estimate | 4.92M | 6M | 29.9M | 42.7M |
Year Ago Sales | 3.37M | 4.13M | 22.39M | 26M |
Sales Growth (year/est) | 36.50% | 28.00% | 16.10% | 55.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.03 | -0.04 | -0.03 | -0.04 |
EPS Actual | 0 | -0.04 | -0.04 | -0.03 |
Difference | 0.03 | 0 | -0.01 | 0.01 |
Surprise % | 100.00% | 0.00% | -33.30% | 25.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.03 | -0.03 | -0.13 | -0.12 |
7 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
30 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
60 Days Ago | -0.04 | -0.04 | -0.15 | -0.14 |
90 Days Ago | -0.04 | -0.04 | -0.15 | -0.14 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | SENS | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 1.60% |
Next Qtr. | 25.00% | -- | -- | 10.50% |
Current Year | -18.20% | -- | -- | 5.20% |
Next Year | 7.70% | -- | -- | 13.30% |
Next 5 Years (per annum) | -27.60% | -- | -- | 11.22% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2023 |
Maintains | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Initiated | Jefferies: Underperform | 7/19/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/11/2023 |
Maintains | HC Wainwright & Co.: Buy | 7/25/2022 |
Related Tickers
ZOM Zomedica Corp.
0.1237
-4.33%
DXCM DexCom, Inc.
130.71
-2.67%
ASXC Asensus Surgical, Inc.
0.2500
-1.07%
TNDM Tandem Diabetes Care, Inc.
30.43
-1.62%
PACB Pacific Biosciences of California, Inc.
1.5500
+6.16%
MOTS Motus GI Holdings, Inc.
0.1735
0.00%
INVO INVO Bioscience, Inc.
1.3700
-9.87%
NNOX Nano-X Imaging Ltd.
8.60
-5.18%
SINT Sintx Technologies, Inc.
0.0418
+4.50%
CATX Perspective Therapeutics, Inc.
1.5000
+2.04%